Clinical Trial Update: Impact of Erythropoietin on Hematological Adaptations and Physical Performance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results assessing how erythropoietin affects hematological adaptations and physical performance in exercise-induced anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exercise-induced Anemia

Drugs mentioned

• Epogen (epoetin alfa) (epoetin alfa)

Snippet

Sponsor: United States Army Research Institute of Environmental Medicine | Conditions: Exercise-Induced Anemia, Physical Performance | Phase 4 | Status: COMPLETED | Results posted: 2025-04-18